Polycystic ovary syndrome how to treat

summary

At present, women are prone to polycystic ovary syndrome, once it occurs, it is easy to lead to infertility, so it does great harm to women's body. Patients with this disease should be treated as soon as possible. Now I will share with you how to treat polycystic ovary syndrome.

Polycystic ovary syndrome how to treat

Method 1: the effect of glucocorticoid and clomiphene combined with adrenocortical hormone is based on its inhibition of excessive androgen secretion from ovary or adrenal gland. Dexamethasone or prednisone is usually used. Within 2 months, the effective rate was 35.7%. The ovarian function of amenorrhea and anovulation can recover slowly. When clomiphene is ineffective in inducing ovulation, dexamethasone can be added in the treatment cycle. This method is very good.

Method 2: clomiphene is the first choice for PCOS. The ovulation rate is 60% - 80%, and the pregnancy rate is 30% - 50%. Clomiphene competes with endogenous estrogen receptor at hypothalamic pituitary level to inhibit negative feedback of estrogen, increase the pulse frequency of GnRH secretion, and adjust the secretion ratio of LH and FSH. Clomiphene also directly promotes ovarian synthesis and secretion of estrogen. After eating this medicine, the ovaries are enlarged due to over stimulation (13.6%), the blood vessels are dilated and there are bursts of fever (10.4%), abdominal discomfort (5.5%), blurred vision (1.5%) or side effects such as rash and mild hair loss. People who are afraid of these side effects should not take it.

Method 3: human gonadotropin (HMG) is mainly used in patients with decreased secretion of endogenous pituitary gonadotropin and estrogen. Urinary gonadotropin (HMG) is an extract purified from the urine of menopausal women, containing FSH and LH in a ratio of 1:1. Each ampoule contains 75u of FSH and LH. Urinary gonadotropin (HMG) is considered as an alternative ovulation inducing drug for the treatment of anovulatory infertility. Because of its more side effects, it is more dangerous to induce ovarian hyperstimulation syndrome (OHSS). The therapeutic dose of hCG should be different from person to person and treatment cycle, and strict monitoring measures should be taken to prevent ovarian hyperstimulation syndrome (OHSS).

matters needing attention

For patients with polycystic ovary syndrome, if they want to recover as soon as possible, it is very important to choose the right treatment method first, and then the nursing during the treatment can not be ignored.